These advanced peptide formulations are produced through an exclusive clinical partnership with Cellgenica global leader in regenerative medicine innovation with over a decade of expertise in peptide science
The company stocked many of the compounds that regularly come up in recovery and performance discussions
Product as described
By binding G-actin, thymosin beta-4 helps regulate the available pool of monomeric actin that cells draw on for cytoskeletal remodeling, which is part of how cells migrate during wound repair
From the periphery, the immediate defensive response can be the stable gastric pentadecapeptide BPC 157 therapy [1,2,3,4,5,6,7,8,9,10,11,15,27,28,29,30,33], peripherally and centrally